What are the limitations of the fong clinical risk score?

While the fong clinical risk score is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the fong clinical risk score to ensure safe bedside use and optimal diagnostic accuracy.

How does the fong clinical risk score compare to other Oncology scores?

The fong clinical risk score is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the fong clinical risk score free to use?

Yes. OpiCalc provides the fong clinical risk score completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

Fong Clinical Risk Score

Gastrointestinal Cancers

Five-factor hepatic colorectal metastasis surgical risk score.

Node-positive primary tumor

Disease-free interval < 12 months

>1 liver metastasis

Largest metastasis > 5 cm

CEA > 200 ng/mL

Calculated Interpretation

Lower-Risk Surgical Candidate

0 /5

More positive Fong factors predict poorer long-term outcome after hepatic resection for CRC metastases.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Five-factor hepatic colorectal metastasis surgical risk score.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Node-positive primary tumor

Disease-free interval < 12 months

>1 liver metastasis

Largest metastasis > 5 cm

CEA > 200 ng/mL

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Five-factor hepatic colorectal metastasis surgical risk score.

OpiCalc Medical Oncology ModuleGastrointestinal Cancers2026

CLINICAL INSIGHT

Background

Context

Fong Clinical Risk Score is included in the oncology module as a structured decision-support tool for gastrointestinal cancers workflows.

No clinical reference data available.

Fong Clinical Risk Score

Gastrointestinal Cancers

Five-factor hepatic colorectal metastasis surgical risk score.

Node-positive primary tumor

Disease-free interval < 12 months

>1 liver metastasis

Largest metastasis > 5 cm

CEA > 200 ng/mL

Calculated Interpretation

Lower-Risk Surgical Candidate

0 /5

More positive Fong factors predict poorer long-term outcome after hepatic resection for CRC metastases.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Primary Use

Five-factor hepatic colorectal metastasis surgical risk score.

CLINICAL INSIGHT

How it Works

Clinical Inputs

Node-positive primary tumor

Disease-free interval < 12 months

>1 liver metastasis

Largest metastasis > 5 cm

CEA > 200 ng/mL

CLINICAL INSIGHT

Practical Pearls

Result Bands

CLINICAL INSIGHT

Next Steps

Suggested Next Steps

Interpret the result in the full disease-specific clinical context.
Correlate with pathology, imaging, performance status, and multidisciplinary guidance.

CLINICAL INSIGHT

Evidence Base

Five-factor hepatic colorectal metastasis surgical risk score.

OpiCalc Medical Oncology ModuleGastrointestinal Cancers2026

CLINICAL INSIGHT

Background

Context

Fong Clinical Risk Score is included in the oncology module as a structured decision-support tool for gastrointestinal cancers workflows.

No clinical reference data available.